trending Market Intelligence /marketintelligence/en/news-insights/trending/snydvisqsgsl9fvueokmgq2 content esgSubNav
In This List

Zai Lab appoints board member

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises

Blog

Essential IR Insights Newsletter - Summer July-August 2023

Blog

Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits


Zai Lab appoints board member

China-based biopharmaceutical company Zai Lab Ltd, which focuses on developing medicines for cancer, autoimmune and infectious diseases, appointed Kai-Xian Chen to its board.

Chen replaces Marietta Wu on the board. He has over 55 years of academic and administrative experience and has also served as a member of the National Committee of Chinese People's Political Consultative Conference from 2007 to 2017.